• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种高效有力的降低 COVID-19 死亡率的非特异性策略。

A highly powerful nonspecific strategy to reduce COVID-19 deaths.

机构信息

School of Life Science and Engineering, Foshan University, Foshan, China.

Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.

出版信息

J Med Virol. 2022 Oct;94(10):5051-5055. doi: 10.1002/jmv.27949. Epub 2022 Jul 1.

DOI:10.1002/jmv.27949
PMID:35729074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9349517/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by the coronavirus severe acute respiratory syndrome coronavirus 2 remains risky worldwide. We elucidate here that good IDM (isolation, disinfection, and maintenance of health) is powerful to reduce COVID-19 deaths based on the striking differences in COVID-19 case fatality rates among various scenarios. IDM means keeping COVID-19 cases away from each other and from other people, disinfecting their living environments, and maintaining their health through good nutrition, rest, and treatment of symptoms and pre-existing diseases (not through specific antiviral therapy). Good IDM could reduce COVID-19 deaths by more than 85% in 2020 and more than 99% in 2022. This is consistent with the fact that good IDM can minimize co-infections and maintain body functions and the fact that COVID-19 has become less pathogenic (this fact was supported with three novel data in this report). Although IDM has been frequently implemented worldwide to some degree, IDM has not been highlighted sufficiently. Good IDM is relative, nonspecific, flexible, and feasible in many countries, and can reduce deaths of some other relatively mild infectious diseases. IDM, vaccines, and antivirals aid each other to reduce COVID-19 deaths. The IDM concept and strategy can aid people to improve their health behavior and fight against COVID-19 and future pandemics worldwide.

摘要

新型冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2 型引起的全球大流行疾病,目前仍具有较高的风险性。本研究通过分析不同场景下 COVID-19 病死率的显著差异,阐明了良好的综合传染病防控措施(隔离、消毒和保持健康)对降低 COVID-19 死亡率具有重要作用。IDM 是指通过保持社交距离、对生活环境进行消毒、通过良好的营养、休息和对症状及基础疾病的治疗来保持健康(而不是通过特定的抗病毒治疗),从而避免 COVID-19 患者及其密切接触者感染他人。在 2020 年和 2022 年,良好的 IDM 可分别降低超过 85%和 99%的 COVID-19 死亡率。这与 IDM 可最大限度减少合并感染和维持身体机能的事实以及 COVID-19 致病性降低的事实相一致(本报告中提供了三个新数据来支持这一事实)。尽管 IDM 在全球范围内已经在一定程度上得到了广泛应用,但仍未得到足够的重视。IDM 是相对的、非特异性的、灵活的、在许多国家都是可行的,并且可以降低一些其他相对温和的传染病的死亡率。IDM、疫苗和抗病毒药物可以相互配合,以降低 COVID-19 的死亡率。IDM 的概念和策略可以帮助人们改善健康行为,共同抗击 COVID-19 及其未来在全球范围内的大流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e6/9349517/194fe54b9006/JMV-94-5051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e6/9349517/2541488b4f52/JMV-94-5051-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e6/9349517/9c59367599d2/JMV-94-5051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e6/9349517/194fe54b9006/JMV-94-5051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e6/9349517/2541488b4f52/JMV-94-5051-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e6/9349517/9c59367599d2/JMV-94-5051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e6/9349517/194fe54b9006/JMV-94-5051-g002.jpg

相似文献

1
A highly powerful nonspecific strategy to reduce COVID-19 deaths.一种高效有力的降低 COVID-19 死亡率的非特异性策略。
J Med Virol. 2022 Oct;94(10):5051-5055. doi: 10.1002/jmv.27949. Epub 2022 Jul 1.
2
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
3
Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19.基于纳米技术的方法和针对 COVID-19 的研究性治疗。
Curr Pharm Des. 2022;28(12):948-968. doi: 10.2174/1381612827666210701150315.
4
Metal-based strategies for the fight against COVID-19.金属基策略在抗击 COVID-19 中的应用。
Chem Commun (Camb). 2022 Jul 5;58(54):7466-7482. doi: 10.1039/d2cc01772e.
5
The Pandemic of Coronavirus Disease 2019 (COVID-19).2019 年冠状病毒病(COVID-19)大流行。
Curr Mol Med. 2022;22(9):761-765. doi: 10.2174/1566524021666211117145216.
6
COVID-19 in Children: Clinical Approach and Management.儿童 COVID-19:临床方法与管理。
Indian J Pediatr. 2020 Jun;87(6):433-442. doi: 10.1007/s12098-020-03292-1. Epub 2020 Apr 27.
7
Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)相关的2019冠状病毒病大流行的出现、传播及潜在治疗靶点
Cell Physiol Biochem. 2020 Aug 25;54(4):767-790. doi: 10.33594/000000254.
8
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
9
Investigational antiviral drugs for the treatment of COVID-19 patients.用于治疗 COVID-19 患者的抗病毒药物研究。
Arch Virol. 2022 Mar;167(3):751-805. doi: 10.1007/s00705-022-05368-z. Epub 2022 Feb 9.
10
Remdesivir against COVID-19 and Other Viral Diseases.瑞德西韦治疗 COVID-19 及其他病毒性疾病。
Clin Microbiol Rev. 2020 Oct 14;34(1). doi: 10.1128/CMR.00162-20. Print 2020 Dec 16.

引用本文的文献

1
Was China's zero-COVID policy the right choice? The multiple factor analysis of variables that affected the course of COVID-19 pandemic in China.中国的“动态清零”政策是正确的选择吗?影响中国 COVID-19 大流行进程的多因素变量分析。
Front Public Health. 2023 Dec 6;11:1252370. doi: 10.3389/fpubh.2023.1252370. eCollection 2023.

本文引用的文献

1
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.奥密克戎变异株感染诱导的有限交叉免疫,未接种疫苗者尤其如此。
Nature. 2022 Jul;607(7918):351-355. doi: 10.1038/s41586-022-04865-0. Epub 2022 May 18.
2
Flu vaccine could cut COVID risk.流感疫苗可降低感染新冠病毒的风险。
Nature. 2022 May;605(7911):602. doi: 10.1038/d41586-022-01315-9.
3
Modeling transmission of SARS-CoV-2 Omicron in China.模拟 SARS-CoV-2 奥密克戎在中国的传播。
Nat Med. 2022 Jul;28(7):1468-1475. doi: 10.1038/s41591-022-01855-7. Epub 2022 May 10.
4
China refuses to end harsh lockdowns.中国拒绝结束严厉的封控。
Science. 2022 Apr 22;376(6591):333-334. doi: 10.1126/science.abq6109. Epub 2022 Apr 21.
5
China can prepare to end its zero-COVID policy.中国可以准备结束其新冠疫情清零政策。
Nat Med. 2022 Jun;28(6):1104-1105. doi: 10.1038/s41591-022-01794-3.
6
The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis.按大洲和国民收入划分的2019冠状病毒病全球病死率:一项荟萃分析。
J Med Virol. 2022 Jun;94(6):2402-2413. doi: 10.1002/jmv.27610. Epub 2022 Feb 25.
7
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
8
Predictors of COVID-19 epidemics in countries of the World Health Organization African Region.世界卫生组织非洲区域国家 COVID-19 疫情的预测因素。
Nat Med. 2021 Nov;27(11):2041-2047. doi: 10.1038/s41591-021-01491-7. Epub 2021 Sep 3.
9
Can we rely on COVID-19 data? An assessment of data from over 200 countries worldwide.我们能否依赖 COVID-19 数据?对来自全球 200 多个国家的数据评估。
Sci Prog. 2021 Apr-Jun;104(2):368504211021232. doi: 10.1177/00368504211021232.
10
Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.COVID-19 合并合并感染患者的影响:系统评价和荟萃分析。
J Med Virol. 2021 Apr;93(4):2385-2395. doi: 10.1002/jmv.26740. Epub 2020 Dec 29.